<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36836568</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">334</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm13020334</ELocationID><Abstract><AbstractText>More than two years after the onset of the COVID-19 pandemic, healthcare providers are facing an emergency within an emergency, the so-called long COVID or post-COVID-19 syndrome (PCS). Patients diagnosed with PCS develop an extended range of persistent symptoms and/or complications from COVID-19. The risk factors and clinical manifestations are many and various. Advanced age, sex/gender, and pre-existing conditions certainly influence the pathogenesis and course of this syndrome. However, the absence of precise diagnostic and prognostic biomarkers may further complicate the clinical management of patients. This review aimed to summarize recent evidence on the factors influencing PCS, possible biomarkers, and therapeutic approaches. Older patients recovered approximately one month earlier than younger patients, with higher rates of symptoms. Fatigue during the acute phase of COVID-19 appears to be an important risk factor for symptom persistence. Female sex, older age, and active smoking are associated with a higher risk of developing PCS. The incidence of cognitive decline and the risk of death are higher in PCS patients than in controls. Complementary and alternative medicine appears to be associated with improvement in symptoms, particularly fatigue. The heterogeneous nature of post-COVID symptoms and the complexity of patients with PCS, who are often polytreated due to concomitant clinical conditions, suggest a holistic and integrated approach to provide useful guidance for the treatment and overall management of long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-6964-2739</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology and Pharmacogenetics Unit, University Hospital "San Giovanni di Dio e Ruggi, D'Aragona", 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corbi</LastName><ForeName>Graziamaria</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3441-889X</Identifier><AffiliationInfo><Affiliation>Department of Translational Medical Sciences, University of Naples "Federico II", 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabbatino</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-6431-8278</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Pascale</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology and Pharmacogenetics Unit, University Hospital "San Giovanni di Dio e Ruggi, D'Aragona", 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sellitto</LastName><ForeName>Carmine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5595-7841</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology and Pharmacogenetics Unit, University Hospital "San Giovanni di Dio e Ruggi, D'Aragona", 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefanelli</LastName><ForeName>Berenice</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7986-8704</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology and Pharmacogenetics Unit, University Hospital "San Giovanni di Dio e Ruggi, D'Aragona", 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertini</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology and Pharmacogenetics Unit, University Hospital "San Giovanni di Dio e Ruggi, D'Aragona", 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Simone</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8172-6134</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liguori</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0232-1452</Identifier><AffiliationInfo><Affiliation>Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Paola</LastName><ForeName>Ilenia</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Bernardo</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4566-0064</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tesse</LastName><ForeName>Angela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2153-4357</Identifier><AffiliationInfo><Affiliation>CNRS, INSERM, L'institut du Thorax, Universit&#xe9; de Nantes, F-44000 Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2366-6556</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagliano</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8109-0655</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippelli</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8235-9118</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via S. Allende, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacology and Pharmacogenetics Unit, University Hospital "San Giovanni di Dio e Ruggi, D'Aragona", 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">gender</Keyword><Keyword MajorTopicYN="N">phytotherapeutics</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>3</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36836568</ArticleId><ArticleId IdType="pmc">PMC9959656</ArticleId><ArticleId IdType="doi">10.3390/jpm13020334</ArticleId><ArticleId IdType="pii">jpm13020334</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Out-break of Novel Coronavirus (2019-nCoV)  [(accessed on 27 December 2022)].  Available online:  https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)</Citation></Reference><Reference><Citation>World Health Organization  WHO Director-General&#x2019;s Opening Remarks at the Media Briefing on COVID-19-11 March 2020.  [(accessed on 27 December 2022)].  Available online:  https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.</Citation></Reference><Reference><Citation>Remuzzi A., Remuzzi G. COVID-19 and Italy: What next? Lancet. 2020;395:1225&#x2013;1228. doi: 10.1016/S0140-6736(20)30627-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30627-9</ArticleId><ArticleId IdType="pmc">PMC7102589</ArticleId><ArticleId IdType="pubmed">32178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti V., Sellitto C., Torsiello M., Manzo V., de Bellis E., Stefanelli B., Bertini N., Costantino M., Maci C., Raschi E., et al. Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review. JAMA Netw. Open. 2022;5:e227970. doi: 10.1001/jamanetworkopen.2022.7970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.7970</ArticleId><ArticleId IdType="pmc">PMC9020212</ArticleId><ArticleId IdType="pubmed">35438752</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliano P., Scarpati G., Sellitto C., Conti V., Spera A.M., Ascione T., Piazza O., Filippelli A. Experimental Pharmacotherapy for COVID-19: The Latest Advances. J. Exp. Pharmacol. 2021;13:1&#x2013;13. doi: 10.2147/JEP.S255209.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JEP.S255209</ArticleId><ArticleId IdType="pmc">PMC7800714</ArticleId><ArticleId IdType="pubmed">33442304</ArticleId></ArticleIdList></Reference><Reference><Citation>The RECOVERY Collaborative Group Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med. 2021;384:693&#x2013;704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti V., Corbi G., Sellitto C., Sabbatino F., Maci C., Bertini N., de Bellis E., Iuliano A., Davinelli S., Pagliano P., et al. Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis. J. Pers. Med. 2021;11:628. doi: 10.3390/jpm11070628.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11070628</ArticleId><ArticleId IdType="pmc">PMC8307114</ArticleId><ArticleId IdType="pubmed">34357095</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliano P., Sellitto C., Scarpati G., Ascione T., Conti V., Franci G., Piazza O., Filippelli A. An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19) Expert Opin. Drug Discov. 2021;17:9&#x2013;18. doi: 10.1080/17460441.2021.1970743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2021.1970743</ArticleId><ArticleId IdType="pmc">PMC8425432</ArticleId><ArticleId IdType="pubmed">34412564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellitto C., Corbi G., Bertini N., Ascione T., Costantino M., Scarpati G., Piazza O., Filippelli A., Conti V., Pagliano P. Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: A systematic review with meta-analysis. J. Chemother. 2022:1&#x2013;14. doi: 10.1080/1120009X.2022.2121091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1120009X.2022.2121091</ArticleId><ArticleId IdType="pubmed">36102273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W., Chen C., Tang J., Wang C., Zhou M., Cheng Y., Zhou X., Wu Q., Zhang X., Feng Z., et al. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: A meta-analysis. Ann. Med. 2022;54:516&#x2013;523. doi: 10.1080/07853890.2022.2034936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2034936</ArticleId><ArticleId IdType="pmc">PMC8820829</ArticleId><ArticleId IdType="pubmed">35118917</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori J., Oudit G.Y., Lopaschuk G.D. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism. Am. J. Physiol. Metab. 2020;319:E43&#x2013;E47. doi: 10.1152/ajpendo.00219.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00219.2020</ArticleId><ArticleId IdType="pmc">PMC7322507</ArticleId><ArticleId IdType="pubmed">32469255</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Lai C.L. SARS-CoV-2 infection: Can ferroptosis be a potential treatment target for multiple organ involvement. Cell Death Discov. 2020;6:130. doi: 10.1038/s41420-020-00369-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-00369-w</ArticleId><ArticleId IdType="pmc">PMC7687212</ArticleId><ArticleId IdType="pubmed">33251029</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.-C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ. Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes-Pacheco M., Silva P.L., Cruz F.F., Battaglini D., Robba C., Pelosi P., Morales M.M., Neves C.C., Rocco P.R.M. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies. Front. Physiol. 2021;12:593223. doi: 10.3389/fphys.2021.593223.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.593223</ArticleId><ArticleId IdType="pmc">PMC7876335</ArticleId><ArticleId IdType="pubmed">33584343</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati A., Pomeranz C., Qamar Z., Thomas S., Frisch D., George G., Summer R., DeSimone J., Sundaram B. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic. Am. J. Med. Sci. 2020;360:5&#x2013;34. doi: 10.1016/j.amjms.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7212949</ArticleId><ArticleId IdType="pubmed">32620220</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliano P., Sellitto C., Conti V., Ascione T., Esposito S. Characteristics of viral pneumonia in the COVID-19 era: An update. Infection. 2021;49:607&#x2013;616. doi: 10.1007/s15010-021-01603-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01603-y</ArticleId><ArticleId IdType="pmc">PMC8006879</ArticleId><ArticleId IdType="pubmed">33782861</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Post COVID-19 Condition (Long COVID)  [(accessed on 27 December 2022)].  Available online:  https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaap G., Wensink M., Doggen C.J.M., van der Palen J., Vonkeman H.E., Bode C. &#x201c;It Really Is an Elusive Illness&#x201d;&#x2014;Post-COVID-19 Illness Perceptions and Recovery Strategies: A Thematic Analysis. Int. J. Environ. Res. Public Health. 2022;19:13003. doi: 10.3390/ijerph192013003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192013003</ArticleId><ArticleId IdType="pmc">PMC9602798</ArticleId><ArticleId IdType="pubmed">36293582</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study. BMJ Open. 2021;11:e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z., Yang M., Lai C.-L. Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans. Biomedicines. 2021;9:966. doi: 10.3390/biomedicines9080966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc H.C., Xiao J., Liu W., Li Y., Chen G. Long COVID and its Management. Int. J. Biol. Sci. 2022;18:4768&#x2013;4780. doi: 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Research  Sex, Age and Existing Health Problems Increase Risk of Long COVID.  [(accessed on 27 December 2022)].  Available online:  https://www.nihr.ac.uk/news/sex-age-and-existing-health-problems-increase-risk-of-long-covid/30882.</Citation></Reference><Reference><Citation>Daitch V., Yelin D., Awwad M., Guaraldi G., Mili&#x107; J., Mussini C., Falcone M., Tiseo G., Carrozzi L., Pistelli F., et al. Characteristics of long-COVID among older adults: A cross-sectional study. Int. J. Infect. Dis. 2022;125:287&#x2013;293. doi: 10.1016/j.ijid.2022.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.09.035</ArticleId><ArticleId IdType="pubmed">36191820</ArticleId></ArticleIdList></Reference><Reference><Citation>Covinsky K.E., Pierluissi E., Johnston C.B. Hospitalization-Associated Disability. JAMA. 2011;306:1782&#x2013;1793. doi: 10.1001/jama.2011.1556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.1556</ArticleId><ArticleId IdType="pubmed">22028354</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Carf&#xec; A., Martis I., Pais C., Ciciarello F., Rota E., Tritto M., Salerno A., Zazzara M.B., Martone A.M., et al. Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study. J. Am. Med. Dir. Assoc. 2021;22:1840&#x2013;1844. doi: 10.1016/j.jamda.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8286874</ArticleId><ArticleId IdType="pubmed">34352201</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotta F., Corbi G., Mazzeo G., Boccia M., Aronne L., D&#x2019;Agnano V., Komici K., Mazzarella G., Parrella R., Bianco A. COVID-19 and the elderly: Insights into pathogenesis and clinical decision-making. Aging Clin. Exp. Res. 2020;32:1599&#x2013;1608. doi: 10.1007/s40520-020-01631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01631-y</ArticleId><ArticleId IdType="pmc">PMC7298699</ArticleId><ArticleId IdType="pubmed">32557332</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz K., G&#x105;sowski J., Michel J.-P., Veronese N. Post-COVID-19 acute sarcopenia: Physiopathology and management. Aging Clin. Exp. Res. 2021;33:2887&#x2013;2898. doi: 10.1007/s40520-021-01942-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-01942-8</ArticleId><ArticleId IdType="pmc">PMC8323089</ArticleId><ArticleId IdType="pubmed">34328636</ArticleId></ArticleIdList></Reference><Reference><Citation>Azkur A.K., Akdis M., Azkur D., Sokolowska M., van de Veen W., Br&#xfc;ggen M., O&#x2019;Mahony L., Gao Y., Nadeau K., Akdis C.A. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020;75:1564&#x2013;1581. doi: 10.1111/all.14364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14364</ArticleId><ArticleId IdType="pmc">PMC7272948</ArticleId><ArticleId IdType="pubmed">32396996</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinchek M., Beiting K.J., Walker J., Graupner J., Huisingh-Scheetz M., Thompson K., Gleason L.J., Levine S. Weight Loss in COVID-19&#x2013;Positive Nursing Home Residents. J. Am. Med. Dir. Assoc. 2021;22:257&#x2013;258. doi: 10.1016/j.jamda.2020.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.11.031</ArticleId><ArticleId IdType="pmc">PMC7699303</ArticleId><ArticleId IdType="pubmed">33352194</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients after Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneroni M., Simonelli C., Saleri M., Bertacchini L., Venturelli M., Troosters T., Ambrosino N., Vitacca M. Muscle Strength and Physical Performance in Patients Without Previous Disabilities Recovering From COVID-19 Pneumonia. Am. J. Phys. Med. Rehabil. 2021;100:105&#x2013;109. doi: 10.1097/PHM.0000000000001641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001641</ArticleId><ArticleId IdType="pubmed">33181531</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneroni M., Pasini E., Vitacca M., Scalvini S., Comini L., Pedrinolla A., Venturelli M. Altered Vascular Endothelium-Dependent Responsiveness in Frail Elderly Patients Recovering from COVID-19 Pneumonia: Preliminary Evidence. J. Clin. Med. 2021;10:2558. doi: 10.3390/jcm10122558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10122558</ArticleId><ArticleId IdType="pmc">PMC8228458</ArticleId><ArticleId IdType="pubmed">34207876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortebein P., Ferrando A., Lombeida J., Wolfe R., Evans W.J. Effect of 10 Days of Bed Rest on Skeletal Muscle in Healthy Older Adults. JAMA. 2007;297:1769&#x2013;1774. doi: 10.1001/jama.297.16.1772-b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.16.1772-b</ArticleId><ArticleId IdType="pubmed">17456818</ArticleId></ArticleIdList></Reference><Reference><Citation>Meftahi G.H., Jangravi Z., Sahraei H., Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: The contribution of &#x201c;inflame-aging&#x201d;. Inflamm. Res. 2020;69:825&#x2013;839. doi: 10.1007/s00011-020-01372-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01372-8</ArticleId><ArticleId IdType="pmc">PMC7289226</ArticleId><ArticleId IdType="pubmed">32529477</ArticleId></ArticleIdList></Reference><Reference><Citation>Bano G., Trevisan C., Carraro S., Solmi M., Luchini C., Stubbs B., Manzato E., Sergi G., Veronese N. Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas. 2017;96:10&#x2013;15. doi: 10.1016/j.maturitas.2016.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2016.11.006</ArticleId><ArticleId IdType="pubmed">28041587</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P.-Y., Li Y., Wang Q. Sarcopenia: An underlying treatment target during the COVID-19 pandemic. Nutrition. 2020;84:111104. doi: 10.1016/j.nut.2020.111104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.111104</ArticleId><ArticleId IdType="pmc">PMC7833321</ArticleId><ArticleId IdType="pubmed">33421827</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantino U., Visconti V.V., Bonanni R., Gatti A., Marcozzi M., Calabr&#xf2; D., Cariati I. Osteosarcopenia and Long-COVID: A dangerous combination. Ther. Adv. Musculoskelet. Dis. 2022;14:1759720X221130485. doi: 10.1177/1759720X221130485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X221130485</ArticleId><ArticleId IdType="pmc">PMC9614591</ArticleId><ArticleId IdType="pubmed">36317068</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazzara M.B., Bellieni A., Calvani R., Coelho-Junior H.J., Picca A., Marzetti E. Inflammaging at the Time of COVID-19. Clin. Geriatr. Med. 2022;38:473&#x2013;481. doi: 10.1016/j.cger.2022.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2022.03.003</ArticleId><ArticleId IdType="pmc">PMC8934712</ArticleId><ArticleId IdType="pubmed">35868667</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Bonafe M., Valensin S., Olivieri F., de Luca M., Ottaviani E., de Benedictis G. Inflamm-aging: An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000;908:244&#x2013;254. doi: 10.1111/j.1749-6632.2000.tb06651.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06651.x</ArticleId><ArticleId IdType="pubmed">10911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L., Fabbri E. Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty. Nat. Rev. Cardiol. 2018;15:505&#x2013;522. doi: 10.1038/s41569-018-0064-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0064-2</ArticleId><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Garagnani P., Parini P., Giuliani C., Santoro A. Inflammaging: A new immune&#x2013;metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 2018;14:576&#x2013;590. doi: 10.1038/s41574-018-0059-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-018-0059-4</ArticleId><ArticleId IdType="pubmed">30046148</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Qu C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.C.S., et al. Clinical Characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Okazaki T., Ebihara S., Mori T., Izumi S., Ebihara T. Association between sarcopenia and pneumonia in older people. Geriatr. Gerontol. Int. 2019;20:7&#x2013;13. doi: 10.1111/ggi.13839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.13839</ArticleId><ArticleId IdType="pubmed">31808265</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz K., G&#x105;sowski J. Risk Factors for Frailty and Cardiovascular Diseases: Are They the Same. Adv. Exp. Med. Biol. 2020;1216:39&#x2013;50. doi: 10.1007/978-3-030-33330-0_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-33330-0_5</ArticleId><ArticleId IdType="pubmed">31894545</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira A.C., Mesquita G., Gomes M.S. Ferritin: An Inflammatory Player Keeping Iron at the Core of Pathogen-Host Interactions. Microorganisms. 2020;8:589. doi: 10.3390/microorganisms8040589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8040589</ArticleId><ArticleId IdType="pmc">PMC7232436</ArticleId><ArticleId IdType="pubmed">32325688</ArticleId></ArticleIdList></Reference><Reference><Citation>Freudenberg-Hua Y., Makhnevich A., Li W., Liu Y., Qiu M., Marziliano A., Carney M., Greenwald B., Kane J.M., Diefenbach M., et al. Psychotropic Medication Use Is Associated with Greater 1-Year Incidence of Dementia after COVID-19 Hospitalization. Front. Med. 2022;9:841326. doi: 10.3389/fmed.2022.841326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.841326</ArticleId><ArticleId IdType="pmc">PMC8972194</ArticleId><ArticleId IdType="pubmed">35372430</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., Lange F.J., Andersson J.L., Griffanti L., Duff E.P., Jbabdi S., et al. Brain imaging before and after COVID-19 in UK Biobank. medRxiv. 2021 doi: 10.1101/2021.06.11.21258690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Bobkova P., Spiridonova E., Shikhaleva A., Gamirova A., Blyuss O., Nekliudov N., Bugaeva P., Andreeva M., DunnGalvin A., et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin. Exp. Allergy. 2021;51:1107&#x2013;1120. doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciarelli V., Nasi M., Bianco F., Seferovic J., Ivkovic V., Gallina S., Mattioli A.V. Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference. Trends Cardiovasc. Med. 2021;32:12&#x2013;17. doi: 10.1016/j.tcm.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8490128</ArticleId><ArticleId IdType="pubmed">34619336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2021;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;.J., Navarro-Pardo E., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg. Health-Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Robineau O., Zins M., Touvier M., Wiernik E., Lemogne C., de Lamballerie X., Blanch&#xe9; H., Deleuze J.-F., Villarroel P.M.S., Dorival C., et al. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated with Their Resolution. JAMA Netw. Open. 2022;5:e2240985. doi: 10.1001/jamanetworkopen.2022.40985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.40985</ArticleId><ArticleId IdType="pmc">PMC9647489</ArticleId><ArticleId IdType="pubmed">36350653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienvenu L.A., Noonan J., Wang X., Peter K. Higher mortality of COVID-19 in males: Sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020;116:2197&#x2013;2206. doi: 10.1093/cvr/cvaa284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa284</ArticleId><ArticleId IdType="pmc">PMC7665363</ArticleId><ArticleId IdType="pubmed">33063089</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein S.L., Flanagan K.L. Sex differences in immune responses. Nat. Rev. Immunol. 2016;16:626&#x2013;638. doi: 10.1038/nri.2016.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti V., Corbi G., Costantino M., Bellis E., Manzo V., Sellitto C., Stefanelli B., Colucci F., Filippelli A. Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics. Biomolecules. 2020;10:1672. doi: 10.3390/biom10121672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10121672</ArticleId><ArticleId IdType="pmc">PMC7765045</ArticleId><ArticleId IdType="pubmed">33327600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., The Long Covid Kids Study Group. Buonsenso D., Carfi A., Malorni W. Long COVID: An estrogen-associated autoimmune disease? Cell Death Discov. 2021;7:77. doi: 10.1038/s41420-021-00464-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00464-6</ArticleId><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbi G., Cacciatore F., Komici K., Rengo G., Vitale D.F., Furgi G., Pagano G., Bencivenga L., Davinelli S., Ferrara N. Inter-relationships between Gender, Frailty and 10-Year Survival in Older Italian Adults: An observational longitudinal study. Sci. Rep. 2019;9:18416. doi: 10.1038/s41598-019-54897-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-54897-2</ArticleId><ArticleId IdType="pmc">PMC6895198</ArticleId><ArticleId IdType="pubmed">31804552</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-H., Wang Y.-R., Wang Q.-H., Chen Y., Chen X., Li Y., Cen Y., Xu C., Hu T., Liu X.-D., et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol. Neurodegener. 2021;16:48. doi: 10.1186/s13024-021-00469-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00469-w</ArticleId><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-H., Chen Y., Wang Q.-H., Wang L.-R., Jiang L., Yang Y., Chen X., Li Y., Cen Y., Xu C., et al. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China. JAMA Neurol. 2022;79:509. doi: 10.1001/jamaneurol.2022.0461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2021;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Thorpe L.E., Simon N.M., de Havenon A., Yaghi S., Sabadia B.S., Yang D., Lewis A., Melmed K., Balcer L.J., et al. Post-acute sequelae of COVID-19 symptom phenotypes and treatment strategies: A prospective, observational study. PLoS ONE. 2022;17:e0275274. doi: 10.1371/journal.pone.0275274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275274</ArticleId><ArticleId IdType="pmc">PMC9521913</ArticleId><ArticleId IdType="pubmed">36174032</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;raas A., B&#xf8; R., Kalleberg K.T., St&#xf8;er N.C., Ellingjord-Dale M., Landr&#xf8; N.I. Self-reported Memory Problems 8 Months after COVID-19 Infection. JAMA Netw. Open. 2021;4:e2118717. doi: 10.1001/jamanetworkopen.2021.18717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.18717</ArticleId><ArticleId IdType="pmc">PMC8322992</ArticleId><ArticleId IdType="pubmed">34323987</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Lindner A., Kofler M., Ianosi B.A., Mahlknecht P., Heim B., Peball M., Carbone F., et al. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study. Eur. J. Neurol. 2022;29:1685&#x2013;1696. doi: 10.1111/ene.15307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15307</ArticleId><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Yin Z., Xu J., Wang S., Liao T., Wang K., Li Y., Yang F., Wang Z., Yang G., et al. Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China. J. Infect. Dis. 2021;224:1473&#x2013;1488. doi: 10.1093/infdis/jiab181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab181</ArticleId><ArticleId IdType="pmc">PMC8083630</ArticleId><ArticleId IdType="pubmed">33822106</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung A.L., Vanderheiden A., Nordvig A.S., Sissoko C.A., Canoll P., Mariani M.B., Jiang X., Bricker T., Rosoklija G.B., Arango V., et al. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain. 2022;145:4193&#x2013;4201. doi: 10.1093/brain/awac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac270</ArticleId><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer D., Snider B.S., Barra M.E., Sanders W.R., Rapalino O., Schaefer P., Foulkes A.S., Bodien Y.G., Edlow B.L. Disturbances of consciousness associated with COVID-19: A Prospective Multimodal Study of Recovery and Brain Connectivity. Neurology. 2022;98:e315&#x2013;e325. doi: 10.1212/WNL.0000000000013067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000013067</ArticleId><ArticleId IdType="pmc">PMC8792809</ArticleId><ArticleId IdType="pubmed">34862317</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams F.M.K., Muirhead N., Pariante C. Covid-19 and chronic fatigue. BMJ. 2020;370:m2922. doi: 10.1136/bmj.m2922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2922</ArticleId><ArticleId IdType="pubmed">32732337</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri K.R., Rukavina K., McConvey V., Antonini A., Lorenzl S., Bhidayasiri R., Piemonte M.E.P., Lim S.-Y., Richfield E., Walker R., et al. The impact of COVID-19 on palliative care for people with Parkinson&#x2019;s and response to future pandemics. Expert Rev. Neurother. 2021;21:615&#x2013;623. doi: 10.1080/14737175.2021.1923480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2021.1923480</ArticleId><ArticleId IdType="pubmed">33905283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Seller A., Mart&#xed;nez Costa L., Hern&#xe1;ndez-Pons A., Valls Pascual E., Solves Alemany A., Albert-Fort M. Ophthalmic and Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 (COVID-19) Ocul Immunol Inflamm. 2020;16:1285&#x2013;1289. doi: 10.1080/09273948.2020.1817497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2020.1817497</ArticleId><ArticleId IdType="pubmed">33021422</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Farr D., Kumar A. Ocular Manifestations of Emerging Flaviviruses and the Blood-Retinal Barrier. Viruses. 2018;10:530. doi: 10.3390/v10100530.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10100530</ArticleId><ArticleId IdType="pmc">PMC6213219</ArticleId><ArticleId IdType="pubmed">30274199</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales J.A., Hinterwirth A., Shantha J., Wang K., Zhong L., Cummings S.L., Qian Y., Wilson M., Acharya N.R., Doan T. Association of Ocular Inflammation and Rubella Virus Persistence. JAMA Ophthalmol. 2019;137:435&#x2013;438. doi: 10.1001/jamaophthalmol.2018.6185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2018.6185</ArticleId><ArticleId IdType="pmc">PMC6439711</ArticleId><ArticleId IdType="pubmed">30589932</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y., Beli E., Calzi S.L., Quigley J.L., Miller R.C., Moldovan L., Feng D., Salazar T.E., Hazra S., Al-Sabah J., et al. Loss of Angiotensin-Converting Enzyme 2 Exacerbates Diabetic Retinopathy by Promoting Bone Marrow Dysfunction. Stem Cells. 2018;36:1430&#x2013;1440. doi: 10.1002/stem.2848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2848</ArticleId><ArticleId IdType="pmc">PMC6410700</ArticleId><ArticleId IdType="pubmed">29761600</ArticleId></ArticleIdList></Reference><Reference><Citation>Casagrande M., Fitzek A., P&#xfc;schel K., Aleshcheva G., Schultheiss H.-P., Berneking L., Spitzer M.S., Schultheiss M. Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients. Ocul. Immunol. Inflamm. 2020;28:721&#x2013;725. doi: 10.1080/09273948.2020.1770301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2020.1770301</ArticleId><ArticleId IdType="pubmed">32469258</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa &#xcd;.F., Bonif&#xe1;cio L.P., Bellissimo-Rodrigues F., Rocha E.M., Jorge R., Bollela V.R., Antunes-Foschini R. Ocular findings among patients surviving COVID-19. Sci. Rep. 2021;11:11085. doi: 10.1038/s41598-021-90482-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90482-2</ArticleId><ArticleId IdType="pmc">PMC8155146</ArticleId><ArticleId IdType="pubmed">34040094</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisdale A.K., Chwalisz B.K. Neuro-ophthalmic manifestations of coronavirus disease 19. Curr. Opin. Ophthalmol. 2020;31:489&#x2013;494. doi: 10.1097/ICU.0000000000000707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICU.0000000000000707</ArticleId><ArticleId IdType="pubmed">33009081</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohamy D., Sharaf M., Abdelazeem K., Saleh M.G., Rateb M.F., Soliman W., Kedwany S.M., Abdelmalek M.O., Medhat M.A., Tohamy A.M., et al. Ocular Manifestations of Post-Acute COVID-19 Syndrome, Upper Egypt Early Report. J. Multidiscip. Health. 2021;14:1935&#x2013;1944. doi: 10.2147/JMDH.S323582.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S323582</ArticleId><ArticleId IdType="pmc">PMC8315779</ArticleId><ArticleId IdType="pubmed">34326644</ArticleId></ArticleIdList></Reference><Reference><Citation>Deb A., Jossy A., Jacob N., Sarkar S., Gokhale T., Kaliaperumal S. COVID-19-associated optic neuritis&#x2014;A case series and review of literature. Indian J. Ophthalmol. 2022;70:310. doi: 10.4103/ijo.IJO_2235_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_2235_21</ArticleId><ArticleId IdType="pmc">PMC8917537</ArticleId><ArticleId IdType="pubmed">34937266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitirgen G., Korkmaz C., Zamani A., Iyisoy M.S., Kerimoglu H., Malik R.A. Quantitative abnormalities of pupillary responses to light following COVID-19. Int Ophthalmol. 2022;42:2847&#x2013;2854. doi: 10.1007/s10792-022-02275-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-022-02275-9</ArticleId><ArticleId IdType="pmc">PMC8980787</ArticleId><ArticleId IdType="pubmed">35380318</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakouny Z., Hawley J.E., Choueiri T.K., Peters S., Rini B.I., Warner J.L., Painter C.A. COVID-19 and Cancer: Current Challenges and Perspectives. Cancer Cell. 2020;38:629&#x2013;646. doi: 10.1016/j.ccell.2020.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2020.09.018</ArticleId><ArticleId IdType="pmc">PMC7528740</ArticleId><ArticleId IdType="pubmed">33049215</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A., Mohammed T.J., Duma N., Garassino M.C., Hicks L.K., Kuderer N.M., Lyman G.H., Mishra S., Pinato D.J., Rini B.I., et al. COVID-19 and Cancer. JAMA Oncol. 2021;7:1882. doi: 10.1001/jamaoncol.2021.4083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2021.4083</ArticleId><ArticleId IdType="pmc">PMC8805603</ArticleId><ArticleId IdType="pubmed">34473192</ArticleId></ArticleIdList></Reference><Reference><Citation>Passaro A., Bestvina C., Velez M.V., Garassino M.C., Garon E., Peters S. Severity of COVID-19 in patients with lung cancer: Evidence and challenges. J. Immunother. Cancer. 2021;9:e002266. doi: 10.1136/jitc-2020-002266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-002266</ArticleId><ArticleId IdType="pmc">PMC7978268</ArticleId><ArticleId IdType="pubmed">33737345</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini K.S., Tagliamento M., Lambertini M., McNally R., Romano M., Leone M., Curigliano G., de Azambuja E. Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. Eur. J. Cancer. 2020;139:43&#x2013;50. doi: 10.1016/j.ejca.2020.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2020.08.011</ArticleId><ArticleId IdType="pmc">PMC7467090</ArticleId><ArticleId IdType="pubmed">32971510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhu F., Xie L., Wang C., Wang J., Chen R., Jia P., Guan H.Q., Peng L., Chen Y., et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann. Oncol. 2020;31:894&#x2013;901. doi: 10.1016/j.annonc.2020.03.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2020.03.296</ArticleId><ArticleId IdType="pmc">PMC7270947</ArticleId><ArticleId IdType="pubmed">32224151</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinato D.J., Tabernero J., Bower M., Scotti L., Patel M., Colomba E., Dolly S., Loizidou A., Chester J., Mukherjee U., et al. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: Evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021;22:1669&#x2013;1680. doi: 10.1016/S1470-2045(21)00573-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(21)00573-8</ArticleId><ArticleId IdType="pmc">PMC8565932</ArticleId><ArticleId IdType="pubmed">34741822</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagher H., Malek A., Chaftari A.-M., Subbiah I.M., Jiang Y., Lamie P., Granwehr B., John T., Guevara E.Y., Borjan J., et al. Long COVID in Cancer Patients: Preponderance of Symptoms in Majority of Patients Over Long Time Period. Open Forum Infect. Dis. 2021;8:S256&#x2013;S257. doi: 10.1093/ofid/ofab466.502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab466.502</ArticleId><ArticleId IdType="pmc">PMC9977271</ArticleId><ArticleId IdType="pubmed">36748905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharafeldin N., Madhira V., Song Q., Bates B., Mitra A.K., Liu F., Bergquist T., Su J., Hsu F.-C., Topaloglu U. Long COVID-19 in patients with cancer: Report from the National COVID Cohort Collaborative (N3C) J. Clin. Oncol. 2022;40:1540. doi: 10.1200/JCO.2022.40.16_suppl.1540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2022.40.16_suppl.1540</ArticleId><ArticleId IdType="pmc">PMC8260918</ArticleId><ArticleId IdType="pubmed">34085538</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini G., Aneja R. Cancer as a prospective sequela of long COVID-19. Bioessays. 2021;43:2000331. doi: 10.1002/bies.202000331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202000331</ArticleId><ArticleId IdType="pmc">PMC8206711</ArticleId><ArticleId IdType="pubmed">33914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31&#x2013;46. doi: 10.1158/2159-8290.CD-21-1059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-21-1059</ArticleId><ArticleId IdType="pubmed">35022204</ArticleId></ArticleIdList></Reference><Reference><Citation>Coussens L.M., Werb Z. Inflammation and cancer. Nature. 2002;420:860&#x2013;867. doi: 10.1038/nature01322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01322</ArticleId><ArticleId IdType="pmc">PMC2803035</ArticleId><ArticleId IdType="pubmed">12490959</ArticleId></ArticleIdList></Reference><Reference><Citation>Greten F.R., Grivennikov S.I. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019;51:27&#x2013;41. doi: 10.1016/j.immuni.2019.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.06.025</ArticleId><ArticleId IdType="pmc">PMC6831096</ArticleId><ArticleId IdType="pubmed">31315034</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapti V., Tsaganos T., Vathiotis I.A., Syrigos N.K., Li P., Poulakou G. New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge. Vaccines. 2022;10:1607. doi: 10.3390/vaccines10101607.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101607</ArticleId><ArticleId IdType="pmc">PMC9611551</ArticleId><ArticleId IdType="pubmed">36298472</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., das Neves P.F.M., Lima S.S., Lopes J.D.C., Torres M.K.D.S., Vallinoto I.M.V.C., Bichara C.D.A., dos Santos E.F., de Brito M.T.F.M., da Silva A.L.S., et al. Cytokine Profiles Associated with Acute COVID-19 and Long COVID-19 Syndrome. Front. Cell. Infect. Microbiol. 2022;12:922422. doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.E., Goldberg S.A., Forman C.A., Munter S.E., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y., Monsalve D.M., Rojas M., Rodr&#xed;guez Y., Zapata E., Ram&#xed;rez-Santana C., Anaya J.-M. Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome. J. Infect. Dis. 2022;225:2155&#x2013;2162. doi: 10.1093/infdis/jiac017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., Sarkar S., Fram T.R., Boppana S., Sterrett S., Qin K., Bansal A., Long D.M., Sabbaj S., Kobie J.J., et al. Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses. J. Clin. Investig. 2021;6:e151544. doi: 10.1172/jci.insight.151544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.151544</ArticleId><ArticleId IdType="pmc">PMC8410022</ArticleId><ArticleId IdType="pubmed">34143754</ArticleId></ArticleIdList></Reference><Reference><Citation>Loretelli C., Abdelsalam A., D&#x2019;Addio F., Ben Nasr M., Assi E., Usuelli V., Maestroni A., Seelam A.J., Ippolito E., di Maggio S., et al. PD-1 blockade counteracts post&#x2013;COVID-19 immune abnormalities and stimulates the anti&#x2013;SARS-CoV-2 immune response. J. Clin. Investig. 2021;6:e146701. doi: 10.1172/jci.insight.146701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.146701</ArticleId><ArticleId IdType="pmc">PMC8783674</ArticleId><ArticleId IdType="pubmed">34784300</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M., Vig&#xf3;n L., Fuertes D., Murciano-Ant&#xf3;n M.A., Casado-Fern&#xe1;ndez G., Dom&#xed;nguez-Mateos S., Mateos E., Ramos-Mart&#xed;n F., Planelles V., Torres M., et al. Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals with Long-COVID: Identification of Diagnostic Biomarkers. Front. Immunol. 2022;13:848886. doi: 10.3389/fimmu.2022.848886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatino F., Conti V., Franci G., Sellitto C., Manzo V., Pagliano P., de Bellis E., Masullo A., Salzano A.F., Caputo A., et al. PD-L1 Dysregulation in COVID-19 Patients. Front. Immunol. 2021;12:695242. doi: 10.3389/fimmu.2021.695242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.695242</ArticleId><ArticleId IdType="pmc">PMC8215357</ArticleId><ArticleId IdType="pubmed">34163490</ArticleId></ArticleIdList></Reference><Reference><Citation>Postow M.A., Callahan M.K., Wolchok J.D. Immune Checkpoint Blockade in Cancer Therapy. J. Clin. Oncol. 2015;33:1974&#x2013;1982. doi: 10.1200/JCO.2014.59.4358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2014.59.4358</ArticleId><ArticleId IdType="pmc">PMC4980573</ArticleId><ArticleId IdType="pubmed">25605845</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong J., Chehrazi-Raffle A., Reddi S., Salgia R. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: A comprehensive review of registration trials and future considerations. J. Immunother. Cancer. 2018;6:8. doi: 10.1186/s40425-018-0316-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40425-018-0316-z</ArticleId><ArticleId IdType="pmc">PMC5778665</ArticleId><ArticleId IdType="pubmed">29357948</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatino F., Liguori L., Pepe S., Ferrone S. Immune checkpoint inhibitors for the treatment of melanoma. Expert Opin. Biol. Ther. 2022;22:563&#x2013;576. doi: 10.1080/14712598.2022.2038132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2022.2038132</ArticleId><ArticleId IdType="pmc">PMC9038682</ArticleId><ArticleId IdType="pubmed">35130816</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M., Chroscicki P., Swatler J., Stepnik D., de Biasi S., Hampel M., Brewinska-Olchowik M., Maliszewska A., Sklinda K., Durlik M., et al. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection. Front. Immunol. 2022;13:886431. doi: 10.3389/fimmu.2022.886431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghezeldasht S.A., Shirdel A., Assarehzadegan M.A., Hassannia T., Rahimi H., Miri R., Rezaee S.A.R. Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL) Iran J Basic Med. Sci. 2013;16:179&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3881257</ArticleId><ArticleId IdType="pubmed">24470860</ArticleId></ArticleIdList></Reference><Reference><Citation>Virz&#xec; A., Suarez A.A.R., Baumert T.F., Lupberger J. Oncogenic Signaling Induced by HCV Infection. Viruses. 2018;10:538. doi: 10.3390/v10100538.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10100538</ArticleId><ArticleId IdType="pmc">PMC6212953</ArticleId><ArticleId IdType="pubmed">30279347</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimmanesh I., Shariati L., Dana N., Esmaeili Y., Vaseghi G., Javanmard S.H. Cancer Occurrence as the Upcoming Complications of COVID-19. Front. Mol. Biosci. 2022;8:813175. doi: 10.3389/fmolb.2021.813175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.813175</ArticleId><ArticleId IdType="pmc">PMC8831861</ArticleId><ArticleId IdType="pubmed">35155571</ArticleId></ArticleIdList></Reference><Reference><Citation>Farahani M., Niknam Z., Amirabad L.M., Amiri-Dashatan N., Koushki M., Nemati M., Pouya F.D., Rezaei-Tavirani M., Rasmi Y., Tayebi L. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed. Pharmacother. 2021;145:112420. doi: 10.1016/j.biopha.2021.112420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112420</ArticleId><ArticleId IdType="pmc">PMC8585639</ArticleId><ArticleId IdType="pubmed">34801852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaiah M.J. mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19. Gene Rep. 2020;20:100765. doi: 10.1016/j.genrep.2020.100765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2020.100765</ArticleId><ArticleId IdType="pmc">PMC7324924</ArticleId><ArticleId IdType="pubmed">32835132</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T., Li X., Zhang J. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy. Int. J. Mol. Sci. 2019;20:755. doi: 10.3390/ijms20030755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20030755</ArticleId><ArticleId IdType="pmc">PMC6387042</ArticleId><ArticleId IdType="pubmed">30754640</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes J.M., Grimes K.V. p38 MAPK inhibition: A promising therapeutic approach for COVID-19. J. Mol. Cell. Cardiol. 2020;144:63&#x2013;65. doi: 10.1016/j.yjmcc.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7228886</ArticleId><ArticleId IdType="pubmed">32422320</ArticleId></ArticleIdList></Reference><Reference><Citation>Leelahavanichkul K., Amornphimoltham P., Molinolo A.A., Basile J.R., Koontongkaew S., Gutkind J.S. A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis. Mol. Oncol. 2013;8:105&#x2013;118. doi: 10.1016/j.molonc.2013.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molonc.2013.10.003</ArticleId><ArticleId IdType="pmc">PMC3946852</ArticleId><ArticleId IdType="pubmed">24216180</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N., Singh A.B. S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: An In Silico study. Transl. Oncol. 2020;13:100814. doi: 10.1016/j.tranon.2020.100814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tranon.2020.100814</ArticleId><ArticleId IdType="pmc">PMC7324311</ArticleId><ArticleId IdType="pubmed">32619819</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng P., Shen P., Shan Y., Yang Y., Deng R., Chen W., Lu Y., Wei Z. Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy. Front. Cell Dev. Biol. 2021;9:626045. doi: 10.3389/fcell.2021.626045.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.626045</ArticleId><ArticleId IdType="pmc">PMC8455814</ArticleId><ArticleId IdType="pubmed">34568308</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A.A., Sirsat A.T., Singh H., Cash P. Microbiota and cancer: Current understanding and mechanistic implications. Clin. Transl. Oncol. 2021;24:193&#x2013;202. doi: 10.1007/s12094-021-02690-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12094-021-02690-x</ArticleId><ArticleId IdType="pmc">PMC8360819</ArticleId><ArticleId IdType="pubmed">34387847</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenazy M.F., Aljohar H.I., Alruwaili A.R., Daghestani M.H., Alonazi M.A., Labban R.S., El-Ansary A.K., Balto H.A. Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications. Metabolites. 2022;12:912. doi: 10.3390/metabo12100912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12100912</ArticleId><ArticleId IdType="pmc">PMC9611210</ArticleId><ArticleId IdType="pubmed">36295814</ArticleId></ArticleIdList></Reference><Reference><Citation>Masir M.N., Shirvaliloo M. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions. JGH Open. 2022;6:667&#x2013;676. doi: 10.1002/jgh3.12811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgh3.12811</ArticleId><ArticleId IdType="pmc">PMC9538198</ArticleId><ArticleId IdType="pubmed">36247234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gang J., Wang H., Xue X., Zhang S. Microbiota and COVID-19: Long-term and complex influencing factors. Front. Microbiol. 2022;13:963488. doi: 10.3389/fmicb.2022.963488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.963488</ArticleId><ArticleId IdType="pmc">PMC9417543</ArticleId><ArticleId IdType="pubmed">36033885</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Gu S., Chen Y., Lu H., Shi D., Guo J., Wu W.-R., Yang Y., Li Y., Xu K.-J., et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2021;71:222&#x2013;225. doi: 10.1136/gutjnl-2021-324090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S., Chen Y., Wu Z., Chen Y., Gao H., Lv L., Guo F., Zhang X., Luo R., Huang C., et al. Alterations of the Gut Microbiota in Patients with Coronavirus Disease 2019 or H1N1 Influenza. Clin. Infect. Dis. 2020;71:2669&#x2013;2678. doi: 10.1093/cid/ciaa709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Wang H., Cui G., Lu H., Wang L., Luo H., Chen X., Ren H., Sun R., Liu W., et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70:1253&#x2013;1265. doi: 10.1136/gutjnl-2020-323826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.-H., Lin S.-W., Shen C.-F., Hsieh K.-S., Cheng C.-M. Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes. Diagnostics. 2022;12:509. doi: 10.3390/diagnostics12020509.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12020509</ArticleId><ArticleId IdType="pmc">PMC8870804</ArticleId><ArticleId IdType="pubmed">35204599</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulou G., Manoloudi E., Repousi N., Skoura L., Hurst T., Karamitros T. Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence. Pathogens. 2022;11:311. doi: 10.3390/pathogens11030311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11030311</ArticleId><ArticleId IdType="pmc">PMC8948624</ArticleId><ArticleId IdType="pubmed">35335635</ArticleId></ArticleIdList></Reference><Reference><Citation>Colarusso C., Maglio A., Terlizzi M., Vitale C., Molino A., Pinto A., Vatrella A., Sorrentino R. Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-&#x3b2; but Higher Levels of IL-1&#x3b1; and TGF-&#x3b2;. Biomedicines. 2021;9:1931. doi: 10.3390/biomedicines9121931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9121931</ArticleId><ArticleId IdType="pmc">PMC8698335</ArticleId><ArticleId IdType="pubmed">34944747</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrella C., Nenna R., Petrarca L., Tarani F., Paparella R., Mancino E., Di Mattia G., Conti M.G., Matera L., Bonci E., et al. Serum NGF and BDNF in Long-COVID-19 Adolescents: A Pilot Study. Diagnostics. 2022;12:1162. doi: 10.3390/diagnostics12051162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12051162</ArticleId><ArticleId IdType="pmc">PMC9140550</ArticleId><ArticleId IdType="pubmed">35626317</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter A.G., Shields A.M., Karim A., Birch D., Faustini S.E., Steadman L., Ward K., Plant T., Reynolds G., Veenith T., et al. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin. Exp. Immunol. 2021;205:99&#x2013;105. doi: 10.1111/cei.13623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13623</ArticleId><ArticleId IdType="pmc">PMC8239842</ArticleId><ArticleId IdType="pubmed">34082475</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A.-T., Wang C.-Y., Zhu W.-L., Chen W. Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review. Aging Dis. 2022;13:144. doi: 10.14336/AD.2021.0704.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0704</ArticleId><ArticleId IdType="pmc">PMC8782553</ArticleId><ArticleId IdType="pubmed">35111367</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., Englert H., Byrne M., Bergin C., O&#x2019;Sullivan J.M., et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C.-Y., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S.-C., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharbi K.S., Singh Y., Almalki W.H., Rawat S., Afzal O., Altamimi A.S.A., Kazmi I., Al-Abbasi A.F., Alzarea S.I., Singh S.K., et al. Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora. Chem. Interactions. 2022;358:109898. doi: 10.1016/j.cbi.2022.109898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2022.109898</ArticleId><ArticleId IdType="pmc">PMC8934739</ArticleId><ArticleId IdType="pubmed">35331679</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M., Artime A., Pariente E., Fierro P., Ruiz Y., Guti&#xe9;rrez S., Tobalina M., D&#xed;az-Salazar S., Ramos C., Olmos J.M., et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: A cross-sectional study. Curr. Med. Res. Opin. 2022;38:901&#x2013;909. doi: 10.1080/03007995.2022.2042991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., Calcaterra I., Molino A., Moretta P., Lupoli R., Spedicato G., Papa A., Motta A., Maniscalco M., di Minno M. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines. 2021;9:957. doi: 10.3390/biomedicines9080957.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080957</ArticleId><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M.A., Knauer M.J., Nicholson M., Daley M., van Nynatten L.R., Martin C., Patterson E.K., Cepinskas G., Seney S.L., Dobretzberger V., et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol. Med. 2022;28:122. doi: 10.1186/s10020-022-00548-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 27 December 2022)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Moschopoulos C.D., Margalit I., Gkrania-Klotsas E., Landi F., Stahl J.-P., Yahav D. ESCMID rapid guidelines for assessment and management of long COVID. Clin. Microbiol. Infect. 2022;28:955&#x2013;972. doi: 10.1016/j.cmi.2022.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Trials.gov.Long COVID - List Results.  [(accessed on 27 December 2022)]; Available online:  https://clinicaltrials.gov/</Citation></Reference><Reference><Citation>Davinelli S., Corbi G., Righetti S., Sears B., Olarte H.H., Grassi D., Scapagnini G. Cardioprotection by Cocoa Polyphenols and &#x3c9;-3 Fatty Acids: A Disease-Prevention Perspective on Aging-Associated Cardiovascular Risk. J. Med. Food. 2018;21:1060&#x2013;1069. doi: 10.1089/jmf.2018.0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2018.0002</ArticleId><ArticleId IdType="pmc">PMC6206547</ArticleId><ArticleId IdType="pubmed">29723102</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr A.C., Rowe S. The Emerging Role of Vitamin C in the Prevention and Treatment of COVID-19. Nutrients. 2020;12:3286. doi: 10.3390/nu12113286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12113286</ArticleId><ArticleId IdType="pmc">PMC7693980</ArticleId><ArticleId IdType="pubmed">33121019</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T., Varnai R., Schranz D., Zavori L., Peterfi Z., Sipos D., T&#x151;k&#xe9;s-F&#xfc;zesi M., Illes Z., Buki A., Csecsei P. Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms. J. Clin. Med. 2021;10:4337. doi: 10.3390/jcm10194337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194337</ArticleId><ArticleId IdType="pmc">PMC8509483</ArticleId><ArticleId IdType="pubmed">34640355</ArticleId></ArticleIdList></Reference><Reference><Citation>Varnai R., Molnar T., Zavori L., T&#x151;k&#xe9;s-F&#xfc;zesi M., Illes Z., Kanizsai A., Csecsei P. Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms. Vaccines. 2022;10:165. doi: 10.3390/vaccines10020165.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020165</ArticleId><ArticleId IdType="pmc">PMC8924883</ArticleId><ArticleId IdType="pubmed">35214624</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.-T., Perrodeau E., Saldanha J., Pane I., Ravaud P. Efficacy of COVID-19 Vaccination on the Symptoms of Patients with Long COVID: A Target Trial Emulation Using Data from the ComPaRe e-Cohort in France. Res. Sq. 2022 doi: 10.2139/ssrn.3932953.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3932953</ArticleId><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari B., Marasini B.P., Rayamajhee B., Bhattarai B.R., Lamichhane G., Khadayat K., Adhikari A., Khanal S., Parajuli N. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID -19: A review. Phytother. Res. 2020;35:1298&#x2013;1312. doi: 10.1002/ptr.6893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6893</ArticleId><ArticleId IdType="pmc">PMC7675695</ArticleId><ArticleId IdType="pubmed">33037698</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmarath W., Mapoung S., Umsumarng S., Arjsri P., Srisawad K., Thippraphan P., Yodkeeree S., Dejkriengkraikul P. Cyanidin-3-O-glucoside and Peonidin-3-O-glucoside-Rich Fraction of Black Rice Germ and Bran Suppresses Inflammatory Responses from SARS-CoV-2 Spike Glycoprotein S1-Induction In Vitro in A549 Lung Cells and THP-1 Macrophages via Inhibition of the NLRP3 Inflammasome Pathway. Nutrients. 2022;14:2738. doi: 10.3390/nu14132738.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14132738</ArticleId><ArticleId IdType="pmc">PMC9268823</ArticleId><ArticleId IdType="pubmed">35807916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharaeva Z., Shokarova A., Shomakhova Z., Ibragimova G., Trakhtman P., Trakhtman I., Chung J., Mayer W., de Luca C., Korkina L. Fermented Carica papaya and Morinda citrifolia as Perspective Food Supplements for the Treatment of Post-COVID Symptoms: Randomized Placebo-Controlled Clinical Laboratory Study. Nutrients. 2022;14:2203. doi: 10.3390/nu14112203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14112203</ArticleId><ArticleId IdType="pmc">PMC9182401</ArticleId><ArticleId IdType="pubmed">35684003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossato M.S., Brilli E., Ferri N., Giordano G., Tarantino G. Observational study on the benefit of a nutritional supplement, supporting immune function and energy metabolism, on chronic fatigue associated with the SARS-CoV-2 post-infection progress. Clin. Nutr. ESPEN. 2021;46:510&#x2013;518. doi: 10.1016/j.clnesp.2021.08.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.08.031</ArticleId><ArticleId IdType="pmc">PMC8420132</ArticleId><ArticleId IdType="pubmed">34857243</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureen Z., Dautaj A., Nodari S., Fioretti F., Dhuli K., Anpilogov K., Lorusso L., Paolacci S., Michelini S., Guda T., et al. Proposal of a food supplement for the management of post-COVID syndrome. Eur. Rev. Med. Pharmacol. Sci. 2021;25:67&#x2013;73. doi: 10.26355/eurrev_202112_27335.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202112_27335</ArticleId><ArticleId IdType="pubmed">34890036</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Calvani R., Picca A., Ciciarello F., Galluzzo V., Coelho-J&#xfa;nior H.J., di Giorgio A., di Mario C., Gervasoni J., Gremese E., et al. Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial. Nutrients. 2022;14:4984. doi: 10.3390/nu14234984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14234984</ArticleId><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Belcaro G., Cornelli U., Cesarone M.R., Scipione C., Scipione V., Hu S., Feragalli B., Corsi M., Cox D., Cotellese R., et al. Preventive effects of Pycnogenol&#xae; on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19) Minerva Med. 2022;113:300&#x2013;308. doi: 10.23736/S0026-4806.21.07650-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0026-4806.21.07650-3</ArticleId><ArticleId IdType="pubmed">34060731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove M., Fogacci F., Quattrocchi S., Veronesi M., Cicero A.F. Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection. Arch. Med. Sci. 2021;17:1797&#x2013;1799. doi: 10.5114/aoms/141502.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms/141502</ArticleId><ArticleId IdType="pmc">PMC8641516</ArticleId><ArticleId IdType="pubmed">34900061</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanelli B., Capone E. Role of the ketogenic diet in alzheimer&#x2019;s disease and parkinson&#x2019;s disease. Pharmacologyonline. 2020;3:188&#x2013;192.</Citation></Reference><Reference><Citation>Goldstein L.H., Elias M., Ron-Avraham G., Biniaurishvili B.Z., Madjar M., Kamargash I., Braunstein R., Berkovitch M., Golik A. Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. Br. J. Clin. Pharmacol. 2007;64:373&#x2013;380. doi: 10.1111/j.1365-2125.2007.02878.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2007.02878.x</ArticleId><ArticleId IdType="pmc">PMC2000642</ArticleId><ArticleId IdType="pubmed">17425631</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanelli B., Sellitto C., de Bellis E., Torsiello M., Bertini N., Pezzullo A.M., Corbi G., Sabbatino F., Pepe S., Tesse A., et al. Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation. Pharmaceuticals. 2022;15:1388. doi: 10.3390/ph15111388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15111388</ArticleId><ArticleId IdType="pmc">PMC9693983</ArticleId><ArticleId IdType="pubmed">36355560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilgi N., Bell K., Ananthakrishnan A.N., Atallah E. Imatinib and Panax Ginseng: A Potential Interaction Resulting in Liver Toxicity. Ann. Pharmacother. 2010;44:926&#x2013;928. doi: 10.1345/aph.1M715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1345/aph.1M715</ArticleId><ArticleId IdType="pubmed">20332334</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti V., Manzo V., de Bellis E., Stefanelli B., Sellitto C., Bertini N., Corbi G., Ferrara N., Filippelli A. Opposite Response to Vitamin K Antagonists: A Report of Two Cases and Systematic Review of Literature. J. Pers. Med. 2022;12:1578. doi: 10.3390/jpm12101578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12101578</ArticleId><ArticleId IdType="pmc">PMC9605490</ArticleId><ArticleId IdType="pubmed">36294717</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalloh M.A., Gregory P.J., Hein D., Cochrane Z.R., Rodriguez A. Dietary supplement interactions with antiretrovirals: A systematic review. Int. J. STD AIDS. 2016;28:4&#x2013;15. doi: 10.1177/0956462416671087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0956462416671087</ArticleId><ArticleId IdType="pubmed">27655839</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera C.S., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteleux B., Henrot P., Ernst R., Grassion L., Raherison-Semjen C., Beaufils F., Zysman M., Delorme M. Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience. Respir. Med. 2021;189:106648. doi: 10.1016/j.rmed.2021.106648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106648</ArticleId><ArticleId IdType="pmc">PMC8511554</ArticleId><ArticleId IdType="pubmed">34689061</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet T. Understanding long COVID: A modern medical challenge. Lancet. 2021;398:725. doi: 10.1016/S0140-6736(21)01900-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01900-0</ArticleId><ArticleId IdType="pmc">PMC8389978</ArticleId><ArticleId IdType="pubmed">34454656</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>